Tag - medicine

 
Menu
Search
 
November 23, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE

Japan Times
WORLD
Nov 9, 2021
Regeneron antibody prevents COVID-19 infections for eight months
The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.
Japan Times
WORLD / ANALYSIS
Nov 9, 2021
COVID-19 pills no substitute for vaccines, disease experts say
Some experts fear the arrival of oral treatments for the coronavirus may further impede vaccination campaigns.
Japan Times
ASIA PACIFIC
Nov 8, 2021
South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.
Japan Times
COMMENTARY / World
Nov 7, 2021
COVID-19 drugs will change the way we live with the virus
New COVID-19 drug approvals couldn't be timelier as hospitals face massive backlogs of delayed procedures.
Japan Times
WORLD / Science & Health / ANALYSIS
Nov 6, 2021
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.'s and Merck & Co. Inc.'s new pills may be just that. But questions remain about their safety and how well they will work.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
COMMENTARY / World
Nov 5, 2021
Lessons ASEAN could learn from Malaysia’s pandemic success
Malaysia has fully vaccinated more than 77% its population, with some 90% of adults — those deemed eligible for the vaccine — receiving a second dose.
Japan Times
COMMENTARY
Nov 3, 2021
Post-pandemic recovery must include the unpaid care economy
The unpaid care sector for the most part remains unaccounted for in standard government policy tools and its work is primarily performed by women.
Japan Times
WORLD / Science & Health
Nov 2, 2021
How often do COVID-19 vaccines cause heart problems in kids?
While the vaccines made by Pfizer-BioNTech and Moderna do seem to be associated with an increased risk of myocarditis, the absolute risk remains very small.
Japan Times
WORLD
Oct 30, 2021
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company's mRNA technology gives it an advantage.
Japan Times
COMMENTARY / World
Oct 24, 2021
The overlooked victims of COVID-19: The children
The isolation measures imposed by the pandemic have severely curtailed social development in children, resulting in a wide array of mental, emotional and behavioral health issues.
Japan Times
COMMENTARY / World
Oct 24, 2021
A dangerous global divide on vaccine access
The inequitable vaccine divide leaves humanity far more vulnerable to the next stage of the pandemic, as well as to any other systemic crisis that may emerge.
Japan Times
WORLD
Oct 23, 2021
Benefits of Pfizer child shot likely outweigh risks, FDA says
Clearing a vaccine for elementary-school age children would mark a major milestone in the pandemic.
Japan Times
JAPAN / Explainer
Oct 20, 2021
Oral drug molnupiravir seen as 'trump card' in Japan's battle against COVID-19
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.
Japan Times
WORLD / Science & Health
Oct 19, 2021
What scientists know about the risk of breakthrough COVID-19 deaths
After former U.S. Secretary of State Colin Powell died Monday from COVID-19 complications, vaccine skeptics immediately seized on news that he had been vaccinated to stoke doubts.
Japan Times
WORLD
Oct 15, 2021
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
Japan Times
WORLD
Oct 14, 2021
Rush to buy Merck’s COVID-19 pill risks leaving poor countries behind
Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.
Japan Times
WORLD / FOCUS
Oct 13, 2021
Why some nations using the same vaccines have deadlier COVID-19 outbreaks
Everything from dose intervals to the behavior of unvaccinated people has shaped the outcome of recent delta-driven waves in different countries.
Japan Times
WORLD
Oct 11, 2021
AstraZeneca drug effective at treating mild COVID-19 symptoms in trial
The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.
Japan Times
WORLD
Oct 11, 2021
Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor
Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.
Tokyo Metro’s overseas efforts begin in earnest with London deal
Tokyo Metro will soon have a role in the running of London's Elizabeth Line, a major train route serving the U.K.’s capital city and environs.
Man charged with murder allegedly made victim date other men for money
A car carrying suspect Ryotaro Masuda, who was indicted for allegedly beating his 25-year-old girlfriend to death, leaves the Shibuya Police Station in Tokyo on Thursday.
Russia fired experimental ballistic missile at Ukraine, Putin says
Ukrainian firefighters work on a spot following an airstrike in Dnipro on Thursday.
Ex-yokozuna Kitanofuji dies at 82
Yokozuna Kitanofuji enters the ring during the May 1970 grand sumo tournament in Tokyo.
The slow-burn success of ‘A Samurai in Time’
A 19th-century warrior gets struck by lightning and wakes to find himself in 21st-century Kyoto in Junichi Yasuda’s surprise hit “A Samurai in Time.”
Shohei Ohtani wins National League MVP award
Shohei Ohtani celebrates after hitting a three-run home run against the Padres during the National League Division Series at Dodger Stadium in Los Angeles last month.
The slow-burn success of ‘A Samurai in Time’
A 19th-century warrior gets struck by lightning and wakes to find himself in 21st-century Kyoto in Junichi Yasuda’s surprise hit “A Samurai in Time.”
Around a quarter of Japan married couples in their 20s met through dating apps
A survey released by an organization promoting “Good Couples Day” shows that 24% of couples in their 20s met their marriage partner through a dating app.
'Tokyo Swindlers': Get deep into the minds of real estate con artists
In Ko Shinjo's "Tokyo Swindlers," a group of con artists manipulates real estate giants into falsified deals within the highly competitive, quick market.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER